These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 8956074

  • 21. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S, Johnson CA, Carter RL, Clayton SD, Rice KC, Xu H, Davis P, Porreca F, Rothman RB.
    J Med Chem; 1998 Jul 16; 41(15):2872-81. PubMed ID: 9667975
    [Abstract] [Full Text] [Related]

  • 22. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
    Bilsky EJ, Qian X, Hruby VJ, Porreca F.
    J Pharmacol Exp Ther; 2000 Apr 16; 293(1):151-8. PubMed ID: 10734164
    [Abstract] [Full Text] [Related]

  • 23. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
    Makó E, Rónai AZ.
    Med Sci Monit; 2001 Apr 16; 7(3):350-6. PubMed ID: 11386008
    [Abstract] [Full Text] [Related]

  • 24. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL, Wang H, Nakashima N, Basbaum AI.
    J Pharmacol Exp Ther; 1998 Jan 16; 284(1):378-87. PubMed ID: 9435201
    [Abstract] [Full Text] [Related]

  • 25. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S, Khare NK, Saini SK, Seitz LE, Bartlett JL, Davis P, Dersch CM, Porreca F, Rothman RB, Bilsky EJ.
    J Med Chem; 2004 Mar 11; 47(6):1400-12. PubMed ID: 14998329
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
    Wilkes BC, Schiller PW.
    Biopolymers; 1995 Mar 11; 37(6):391-400. PubMed ID: 8589244
    [Abstract] [Full Text] [Related]

  • 28. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.
    Neuroscience; 2005 Mar 11; 135(1):213-25. PubMed ID: 16111831
    [Abstract] [Full Text] [Related]

  • 29. Helix-inducing alpha-aminoisobutyric acid in opioid mimetic deltorphin C analogues.
    Bryant SD, Guerrini R, Salvadori S, Bianchi C, Tomatis R, Attila M, Lazarus LH.
    J Med Chem; 1997 Aug 01; 40(16):2579-87. PubMed ID: 9258365
    [Abstract] [Full Text] [Related]

  • 30. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
    Schiller PW, Nguyen TM, Weltrowska G, Wilkes BC, Marsden BJ, Lemieux C, Chung NN.
    Proc Natl Acad Sci U S A; 1992 Dec 15; 89(24):11871-5. PubMed ID: 1334552
    [Abstract] [Full Text] [Related]

  • 31. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 15; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 32. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
    Fowler CB, Pogozheva ID, Lomize AL, LeVine H, Mosberg HI.
    Biochemistry; 2004 Dec 21; 43(50):15796-810. PubMed ID: 15595835
    [Abstract] [Full Text] [Related]

  • 33. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
    Hosohata K, Varga EV, Alfaro-Lopez J, Tang X, Vanderah TW, Porreca F, Hruby VJ, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 2003 Feb 21; 304(2):683-8. PubMed ID: 12538822
    [Abstract] [Full Text] [Related]

  • 34. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J, Waser B, Schaer JC, Cescato R, Brazeau JF, Rivier J, Reubi JC.
    J Med Chem; 2003 Dec 18; 46(26):5597-605. PubMed ID: 14667214
    [Abstract] [Full Text] [Related]

  • 35. Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro.
    Shook JE, Pelton JT, Wire WS, Hirning LD, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1987 Mar 18; 240(3):772-7. PubMed ID: 2882015
    [Abstract] [Full Text] [Related]

  • 36. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
    Shook JE, Pelton JT, Lemcke PK, Porreca F, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1987 Jul 18; 242(1):1-7. PubMed ID: 2886635
    [Abstract] [Full Text] [Related]

  • 37. [Aladan3]TIPP: a fluorescent delta-opioid antagonist with high delta-receptor binding affinity and delta selectivity.
    Chen H, Chung NN, Lemieux C, Zelent B, Vanderkooi JM, Gryczynski I, Wilkes BC, Schiller PW.
    Biopolymers; 2005 Jul 18; 80(2-3):325-31. PubMed ID: 15614807
    [Abstract] [Full Text] [Related]

  • 38. Bioactivity of new mu and delta opioid peptides.
    Capasso A.
    Med Chem; 2007 Sep 18; 3(5):480-7. PubMed ID: 17897075
    [Abstract] [Full Text] [Related]

  • 39. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
    Kramer TH, Shook JE, Kazmierski W, Ayres EA, Wire WS, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1989 May 18; 249(2):544-51. PubMed ID: 2566679
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).
    Fichna J, do-Rego JC, Chung NN, Lemieux C, Schiller PW, Poels J, Broeck JV, Costentin J, Janecka A.
    J Med Chem; 2007 Feb 08; 50(3):512-20. PubMed ID: 17266203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.